Ncardia

Ncardia is a human iPSC technology company enabling drug innovators to confidently advance the discovery and development of breakthrough therapeutics.

With a strong focus on delivering quality and excelling customer service, we combine top-tier iPSC expertise with deep application knowledge, to enhance the chances of clinical success for any drug modality, gene and cell therapy.

As pioneers in iPSC technology, we facilitate faster progress to your goals and enable earlier critical decision-making in the development of new gene and cell therapies.

Our Capabilities:

Whether you seek high-quality cells, relevant screening assays or robust iPSC differentiation processes, we are ready to help you out.

For more information, visit www.ncardia.com